MSI
69
-3
INTC
37
-4
VRTX
56
-4
AIZ
71
-2
AEP
59
-3
FMC
36
3
SE
65
4
DVN
35
2
FLS
46
-7
ES
55
-5
LH
55
2
AAL
47
-3
MMC
60
-2
NWL
32
-3
CMCSA
52
6
LB
41
-11
LUV
36
7
ETN
73
-2
PYPL
45
-2
DTE
56
-7
MSI
69
-3
INTC
37
-4
VRTX
56
-4
AIZ
71
-2
AEP
59
-3
FMC
36
3
SE
65
4
DVN
35
2
FLS
46
-7
ES
55
-5
LH
55
2
AAL
47
-3
MMC
60
-2
NWL
32
-3
CMCSA
52
6
LB
41
-11
LUV
36
7
ETN
73
-2
PYPL
45
-2
DTE
56
-7
Financhill
Back

Bolt Biotherapeutics 10K Form

Sell
42

BOLT
Bolt Biotherapeutics

Last Price:
0.63
Seasonality Move:
-38.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BOLT News And Ratings

See the #1 stock for the next 7 days that we like better than BOLT

BOLT Financial Statistics

Sales & Book Value

Annual Sales: $7.88M
Cash Flow: $-16.14M
Price / Cash Flow: 0
Annual Sales: $2.24
Price / Book: 0.28

Profitability

EPS (TTM): -1.74000
Net Income (TTM): $-66.17M
Gross Margin: $34.4M
Return on Equity: -57.72%
Return on Assets: -41.72%

Bolt Biotherapeutics Earnings Forecast

Key Bolt Biotherapeutics Financial Ratios

  • The Gross Profit Margin over the past 10 years for BOLT is 50.96%.
  • The Selling, General & Administrative Expenses for BOLT have been equal to 286.06% of Gross Profit Margin.
  • The Research & Development expenses have been 781.39% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of BOLT is -878.58% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 9 years.

Bolt Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BOLT
Website: boltbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.28
Quick Ratio: 4.12

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BOLT Technical Analysis vs Fundamental Analysis

Sell
42
Bolt Biotherapeutics (BOLT) is a Sell

Is Bolt Biotherapeutics a Buy or a Sell?